Japan’s Approach to Pediatric Drug Development: What You Need to Know Blog 小児用医薬品開発に対する日本のアプローチ:知っておくべき情報 Access to safe and effective medications is critical for pediatric patients, yet 60-70% of medicines…Certara2023年5月22日
What is a Global Risk Mitigation Plan & how can you use it to ensure a successful drug launch? ブログ What is a Global Risk Mitigation Plan & how can you use it to ensure a successful drug launch? A Global Risk Mitigation Plan (GRMP) is a critical step in drug development as it…Certara2023年5月4日
SEND Dataset Quality Control: Best Practices & Recommendations Blog SEND Dataset Quality Control: Best Practices & Recommendations In this blog, Senior Product Management Director Peggy Zorn explores best practices & recommendations for…Certara2023年4月25日
Innovating Sales & Marketing Digital Engagement for Pharma and Med Tech Blog Innovating Sales & Marketing Digital Engagement for Pharma and Med Tech The regulatory environment for Pharma and Med Tech creates business challenges for digital engagement. Many…Certara2023年4月21日
Stepwise PIPs: A Solution for the Challenges of Pediatric Drug Development Blog Stepwise PIPs: A Solution for the Challenges of Pediatric Drug Development Early paediatric investigation plan (PIP) submissions – an unnecessarily bitter medicine? In the European Union…Certara2023年4月14日
Considerations for Pricing & Formulary Access for DRG-Funded Hospital Drugs Blog Considerations for Pricing & Formulary Access for DRG-Funded Hospital Drugs In the United States, treatments or medical services that require the patient be admitted into…Certara2023年4月6日
Tips & Tricks for Optimizing Your Pharmacokinetic Modeling & Simulation Blog 薬物動態モデリング&シミュレーションを最適化するためのヒント 専門家のアドバイスで、PK/PDワークフローを効率化する方法を学びましょう。Certara2023年3月23日
Leveraging AI to Accelerate Drug Discovery: Vyasa Joins Certara Blog 創薬を加速させるAIの活用:サターラがVyasaを買収 Applying Vyasa’s deep learning expertise to Certara products will enable our clients to expand how…Certara2023年3月10日
Drug Development Considerations for Live Biotherapeutic Products Blog Drug Development Considerations for Live Biotherapeutic Products A new class of complex biologics has emerged in recent years. These are classified in…Certara2023年3月3日
Common Clinical Trial Disclosure Challenges & Potential Solutions Blog Common Clinical Trial Disclosure Challenges & Potential Solutions Pharmaceutical companies are being required to be more transparent through the timely disclosure of more…Certara2023年2月24日